Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHA:688179)
China
· Delayed Price · Currency is CNY 18.57
+0.35 (1.92%)
At close: Mar 10, 2026
SHA:688179 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 686.46 | 524.39 | 396.72 | 371.02 | 281.25 | Upgrade
|
| Other Revenue | - | 9.17 | 6.16 | 7.08 | 6.41 | Upgrade
|
| Revenue | 686.46 | 533.56 | 402.88 | 378.1 | 287.66 | Upgrade
|
| Revenue Growth (YoY) | 28.66% | 32.44% | 6.55% | 31.44% | 22.82% | Upgrade
|
| Cost of Revenue | - | 204.38 | 162.54 | 156.28 | 110.11 | Upgrade
|
| Gross Profit | 686.46 | 329.18 | 240.33 | 221.82 | 177.55 | Upgrade
|
| Selling, General & Admin | - | 132.56 | 96.08 | 83.96 | 61.35 | Upgrade
|
| Research & Development | - | 62.51 | 51.07 | 38.7 | 22.32 | Upgrade
|
| Other Operating Expenses | 532.13 | 4.49 | 0.78 | 3.22 | 1.52 | Upgrade
|
| Operating Expenses | 532.13 | 200.69 | 148.1 | 127.2 | 85.52 | Upgrade
|
| Operating Income | 154.33 | 128.49 | 92.23 | 94.63 | 92.03 | Upgrade
|
| Interest Expense | - | -7.29 | -6.69 | -4.67 | -0.41 | Upgrade
|
| Interest & Investment Income | - | 5.87 | 6.89 | 8.28 | 10.16 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.01 | 0.11 | 0.4 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.11 | -1.16 | -0.57 | -0.69 | -0.4 | Upgrade
|
| EBT Excluding Unusual Items | 154.44 | 125.92 | 91.97 | 97.95 | 101.27 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.55 | 1.46 | 1.3 | 0.35 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.1 | -0.13 | 0.19 | -1.47 | Upgrade
|
| Other Unusual Items | - | 1.27 | 1.6 | 6.24 | 1.56 | Upgrade
|
| Pretax Income | 154.44 | 127.63 | 94.91 | 105.67 | 101.71 | Upgrade
|
| Income Tax Expense | 50.99 | 11.91 | 9.08 | 12.9 | 12.35 | Upgrade
|
| Earnings From Continuing Operations | 103.45 | 115.72 | 85.83 | 92.77 | 89.36 | Upgrade
|
| Minority Interest in Earnings | - | -16.96 | - | - | - | Upgrade
|
| Net Income | 103.45 | 98.76 | 85.83 | 92.77 | 89.36 | Upgrade
|
| Net Income to Common | 103.45 | 98.76 | 85.83 | 92.77 | 89.36 | Upgrade
|
| Net Income Growth | 4.75% | 15.07% | -7.48% | 3.82% | 20.06% | Upgrade
|
| Shares Outstanding (Basic) | 334 | 329 | 294 | 339 | 331 | Upgrade
|
| Shares Outstanding (Diluted) | 334 | 339 | 303 | 346 | 331 | Upgrade
|
| Shares Change (YoY) | -1.44% | 11.75% | -12.51% | 4.75% | 25.43% | Upgrade
|
| EPS (Basic) | 0.31 | 0.30 | 0.29 | 0.27 | 0.27 | Upgrade
|
| EPS (Diluted) | 0.31 | 0.29 | 0.28 | 0.27 | 0.27 | Upgrade
|
| EPS Growth | 6.27% | 2.96% | 5.75% | -0.89% | -4.29% | Upgrade
|
| Free Cash Flow | - | 115.99 | 10.11 | -105.23 | -98.38 | Upgrade
|
| Free Cash Flow Per Share | - | 0.34 | 0.03 | -0.30 | -0.30 | Upgrade
|
| Dividend Per Share | - | 0.167 | 0.179 | 0.106 | 0.121 | Upgrade
|
| Dividend Growth | - | -6.66% | 68.02% | -12.51% | -19.96% | Upgrade
|
| Gross Margin | 100.00% | 61.70% | 59.65% | 58.67% | 61.72% | Upgrade
|
| Operating Margin | 22.48% | 24.08% | 22.89% | 25.03% | 31.99% | Upgrade
|
| Profit Margin | 15.07% | 18.51% | 21.30% | 24.54% | 31.06% | Upgrade
|
| Free Cash Flow Margin | - | 21.74% | 2.51% | -27.83% | -34.20% | Upgrade
|
| EBITDA | 178.52 | 152.67 | 109.47 | 107.33 | 101.74 | Upgrade
|
| EBITDA Margin | 26.01% | 28.61% | 27.17% | 28.38% | 35.37% | Upgrade
|
| D&A For EBITDA | 24.19 | 24.19 | 17.24 | 12.7 | 9.72 | Upgrade
|
| EBIT | 154.33 | 128.49 | 92.23 | 94.63 | 92.03 | Upgrade
|
| EBIT Margin | 22.48% | 24.08% | 22.89% | 25.03% | 31.99% | Upgrade
|
| Effective Tax Rate | 33.02% | 9.33% | 9.56% | 12.21% | 12.14% | Upgrade
|
| Revenue as Reported | - | 533.56 | 402.88 | 378.1 | 287.66 | Upgrade
|
| Advertising Expenses | - | 11.44 | 5.46 | 3.9 | 3.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.